Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man January 1, 2003
No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study February 1, 2001
Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action December 1, 1998
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis October 14, 1996
Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity April 2, 1995
